Focus Global

France is moving closer to the launch of a medical cannabis trial which could benefit 3,000 patients. The French National Assembly is expected to give approval to the two-year trial which is being backed by president Macron’s La République En Marche majority party, reports Marijuana Business Daily

Globally, a preference for medical cannabis on the market has increased over the last few years, even in places where generalized use and sale of cannabis has been legalized. This trend has continued as the more and more consumers recognize the merits of medical cannabis increases, especially when compared to unregulated crops.

Endometriosis is a chronic, inflammatory condition where tissue similar to the lining of the uterus is found outside of the womb. It affects around one in ten women of reproductive age, causing pain, infertility and gastrointestinal symptoms. Women often report difficulty getting their pain and other symptoms under control, despite medication or even surgery. Our research, published today, found one in ten Australian women with endometriosis reported using cannabis to manage their pain and other symptoms.

The barriers facing patients accessing medicinal cannabis will be placed under scrutiny during a Parliamentary inquiry into how Australia regulates the drug.

Among professional sports, who would’ve selected golf as the catalyst to shift marijuana policy for athletes? Not us, but golf finds itself in a unique position compared to other sports. While it’s an open secret that football and basketball players use cannabis, we usually only hear about their support for policy change or the launch of their new marijuana brand after these same athletes retire.

A study on the potential role of hemp-derived cannabidiol as an alternative to opioids for pain patients has indicated positive results. Dr Alex Capano, Chief Science Officer of Ecofibre’s Ananda Health business in the United States, led a study involving the use of cannabidiol (CBD) to reduce the use of opioids in the treatment of chronic pain.

Thomas Perko of the Medical Cannabis Society shares his thoughts on the challenges facing both patients and companies regarding medical cannabis in Pennsylvania.

American businesses and investors looking for advanced information on the plant are turning to the Jewish State, where the government not only allows research, but funds it